Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cancer Medicine
|
August 29, 2025
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis
Gabrielle Brown, Pavlos Msaouel, Avital M Miller, et al.
JCO Oncology Practice
|
January 8, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials
Avital M Miller, Adina H Passy, Alexander D Sherry, et al.
Cancer
|
February 7, 2026
Control arm overperformance in phase 3 oncology clinical trials
Ansel P Nalin, Pavlos Msaouel, Adam J Grippin, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
September 5, 2025
Mastectomy and breast augmentation outcomes among nonbinary, transgender, and cisgender adults
Amitai S Miller, Maria J Escobar-Domingo, Avital M Miller, et al.
JCO Clinical Cancer Informatics
|
August 30, 2024
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses
Alexander D Sherry, Adina H Passy, Zachary R McCaw, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2025
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study
Troy J Kleber, Alexander D Sherry, Andrew J Arifin, et al.
British Journal of Cancer
|
August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
JAMA Oncology
|
June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis
Alexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cancer Medicine
|
August 29, 2025
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis
Gabrielle Brown, Pavlos Msaouel, Avital M Miller, et al.
JCO Oncology Practice
|
January 8, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials
Avital M Miller, Adina H Passy, Alexander D Sherry, et al.
Cancer
|
February 7, 2026
Control arm overperformance in phase 3 oncology clinical trials
Ansel P Nalin, Pavlos Msaouel, Adam J Grippin, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
September 5, 2025
Mastectomy and breast augmentation outcomes among nonbinary, transgender, and cisgender adults
Amitai S Miller, Maria J Escobar-Domingo, Avital M Miller, et al.
JCO Clinical Cancer Informatics
|
August 30, 2024
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses
Alexander D Sherry, Adina H Passy, Zachary R McCaw, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2025
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study
Troy J Kleber, Alexander D Sherry, Andrew J Arifin, et al.
British Journal of Cancer
|
August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials
Alexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
JAMA Oncology
|
June 1, 2025
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials: A Meta-Epidemiological Analysis
Alexander D Sherry, Avital M Miller, Jnana Preeti Parlapalli, et al.
Page
of 2